Assessment of Systemic Immune-inflammation Index Levels in Patients with Retinal Vein Occlusion

References

• Rogers S, McIntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;117:313–319. doi:10.1016/j.ophtha.2009.07.017.
   PubMed Web of Science ®Google Scholar
• Garcia-Horton A, Al-Ani F, Lazo-Langner A. Retinal vein thrombosis: the Internist’s role in the etiologic and therapeutic management. Thromb Res. 2016;148:118–124. doi:10.1016/j.thromres.2016.11.004.
   PubMed Web of Science ®Google Scholar
• Ponto KA, Scharrer I, Binder H, et al. Hypertension and multiple cardiovascular risk factors increase the risk for retinal vein occlusions: results from the Gutenberg Retinal Vein Occlusion Study. J Hypertens. 2019;37:1372–1383. doi:10.1097/HJH.0000000000002057.
   PubMed Web of Science ®Google Scholar
• Kesler A, Shalev V, Rogowski O, et al. Comparative analysis of homocysteine concentrations in patients with retinal vein occlusion versus thrombotic and atherosclerotic disorders. Blood Coagul Fibrin. 2008;19:259–262. doi:10.1097/MBC.0b013e3282f2b60e.
   PubMed Web of Science ®Google Scholar
• Guthrie GJ, Charles KA, Roxburgh CS, et al. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88:218–230. doi:10.1016/j.critrevonc.2013.03.010.
   PubMed Web of Science ®Google Scholar
• Duan Z, Wang H, Wang Z, et al. Neutrophil-lymphocyte ratio predicts functional and safety outcomes after endovascular treatment for acute ischemic stroke. Cerebrovasc Dis. 2018;45:221–227. doi:10.1159/000489401.
   PubMed Web of Science ®Google Scholar
• Furuncuoglu Y, Tulgar S, Dogan AN, et al. How obesity affects the neutrophil/lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study. Eur Rev Med Pharmacol Sci. 2016;20:1300–1306.
   PubMed Web of Science ®Google Scholar
• Sengul EA, Artunay O, Kockar A, et al. Correlation of neutrophil/lymphocyte and platelet/lymphocyte ratio with visual acuity and macular thickness in age-related macular degeneration. Int J Ophthalmol. 2017;10:754–759. doi:10.18240/ijo.2017.05.16.
   PubMed Web of Science ®Google Scholar
• Şatırtav G, Mirza E, Oltulu R, et al. Assessment of Monocyte/HDL ratio in branch retinal vein occlusion. Ocul Immunol Inflamm. 2020;28:463–467. doi:10.1080/09273948.2019.1569244.
   PubMed Web of Science ®Google Scholar
• Ilhan C, Citirik M, Uzel MM, et al. The usefulness of systemic inflammatory markers as diagnostic indicators of the pathogenesis of diabetic macular edema. Arq Bras Oftalmol. 2020;83:299–304. doi:10.5935/0004-2749.20200051.
   PubMed Web of Science ®Google Scholar
• Ozgonul C, Sertoglu E, Mumcuoglu T, et al. Prediction of pseudoexfoliation syndrome and pseudoexfoliation glaucoma by using neutrophil to lymphocyte ratio and platelet to lymphocyte ratio. Ocul Immunol Inflamm. 2016;24:665–670. doi:10.3109/09273948.2015.1063671.
   PubMed Web of Science ®Google Scholar
• Turkseven KE, Yenerel NM, Ercalik NY, et al. Neutrophil/lymphocyte ratio and mean platelet volume in branch retinal vein occlusion. Saudi J Ophthalmol. 2016;30:105–108. doi:10.1016/j.sjopt.2016.02.003.
   PubMedGoogle Scholar
• Kurtul BE, Cakmak AI, Elbeyli A, et al. Assessment of platelet-to-lymphocyte ratio in patients with retinal vein occlusion. Ther Adv Ophthalmol. 2020;12:97169491.
   Web of Science ®Google Scholar
• Zhu DD, Liu X. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in branch retinal vein occlusion. J Ophthalmol. 2019;2019:6043612. doi:10.1155/2019/6043612.
   PubMed Web of Science ®Google Scholar
• Candemir M, Kiziltunc E, Nurkoc S, et al. Relationship between systemic immune-inflammation index (SII) and the severity of stable coronary artery disease. Angiology. 2021;72:575–581. doi:10.1177/0003319720987743.
   PubMed Web of Science ®Google Scholar
• Yang Y-L, Wu C-H, Hsu P-F, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230. doi:10.1111/eci.13230.
   PubMed Web of Science ®Google Scholar
• Trifan G, Testai FD. Systemic immune-inflammation (SII) index predicts poor outcome after spontaneous supratentorial intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2020;29:105057. doi:10.1016/j.jstrokecerebrovasdis.2020.105057.
   PubMed Web of Science ®Google Scholar
• Alifano M. Systemic immune-inflammation index and prognosis of advanced non-small cell lung cancer. Ann Transl Med. 2020;8:667. doi:10.21037/atm.2020.03.174.
   PubMed Web of Science ®Google Scholar
• Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20:6212–6222. doi:10.1158/1078-0432.CCR-14-0442.
   PubMed Web of Science ®Google Scholar
• Elbeyli A, Kurtul BE. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio levels are associated with keratoconus. Indian J Ophthalmol. 2021;69:1725–1729. doi:10.4103/ijo.IJO_3011_20.
   PubMed Web of Science ®Google Scholar
• Ozarslan OD, Kurtul BE, and Ozcan SC, et al. Increased systemic immune-inflammation index levels in patients with dry eye disease. Ocul Immunol Inflamm. 2020;1–5. doi:10.1080/09273948.2020.1821899.
   Google Scholar
• Kurtul BE, Cakmak AI, Elbeyli A, et al. Evaluation of systemic immune-inflammation index level as a novel marker for severity of noninfectious uveitis. Int Ophthalmol. 2021. doi:10.1007/s10792-021-01924-9.
   PubMedGoogle Scholar
• Elbeyli A, Kurtul BE, and Ozcan SC, et al. The diagnostic value of systemic immune-inflammation index in diabetic macular oedema. Clin Exp Optom. 2021;1–5. doi:10.1080/08164622.2021.1994337.
   Google Scholar
• Kocak N, Eraydin B, Turunc M, et al. Serum inflammatory biomarkers in patients with nonarteritic anterior ischemic optic neuropathy. Korean J Ophthalmol. 2020;34:478–484. doi:10.3341/kjo.2020.0075.
   PubMedGoogle Scholar
• Yau JW, Lee P, Wong TY, et al. Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Intern Med J. 2008;38:904–910. doi:10.1111/j.1445-5994.2008.01720.x.
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med. 1999;340:115–126. doi:10.1056/NEJM199901143400207.
   PubMed Web of Science ®Google Scholar
• Leoncini G, Signorello MG, Segantin A, et al. In retinal vein occlusion platelet response to thrombin is increased. Thromb Res. 2009;124:e48–e55. doi:10.1016/j.thromres.2009.07.010.
   PubMed Web of Science ®Google Scholar
• Goel MS, Diamond SL. Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets. J Biol Chem. 2003;278:9458–9463. doi:10.1074/jbc.M211956200.
   PubMed Web of Science ®Google Scholar
• Zhang R, Brennan ML, Fu X, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA. 2001;286:2136–2142. doi:10.1001/jama.286.17.2136.
   PubMed Web of Science ®Google Scholar
• Gurm HS, Bhatt DL, Lincoff AM, et al. Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart. 2003;89:1200–1204. doi:10.1136/heart.89.10.1200.
   PubMed Web of Science ®Google Scholar
• Tran HV, Erskine NA, Nguyen HL, et al. Increase in white blood cell count is associated with the development of atrial fibrillation after an acute coronary syndrome. Int J Cardiol. 2019;274:138–143. doi:10.1016/j.ijcard.2018.06.007.
   PubMed Web of Science ®Google Scholar
• Wan W, Liu H, Long Y, et al. The association between circulating neutrophil extracellular trap related biomarkers and retinal vein occlusion incidence: a case-control pilot study. Exp Eye Res. 2021;210:108702. doi:10.1016/j.exer.2021.108702.
   PubMed Web of Science ®Google Scholar
• Bian C, Wu Y, Shi Y, et al. Predictive value of the relative lymphocyte count in coronary heart disease. Heart Vessels. 2010;25:469–473. doi:10.1007/s00380-010-0010-7.
   PubMed Web of Science ®Google Scholar
• Wang Q, Ma J, Jiang Z, et al. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute pulmonary embolism: a systematic review and meta-analysis. Int Angiol. 2018;37:4–11. doi:10.23736/S0392-9590.17.03848-2.
   PubMed Web of Science ®Google Scholar
• Dursun A, Ozturk S, Yucel H, et al. Association of neutrophil/lymphocyte ratio and retinal vein occlusion. Eur J Ophthalmol. 2015;25(4):343–346. doi:10.5301/ejo.5000570.
   PubMed Web of Science ®Google Scholar
• Sahin M, Elbey B, Sahin A, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in retinal vein occlusion. Clin Exp Optom. 2020;103:490–494. doi:10.1111/cxo.13008.
   PubMed Web of Science ®Google Scholar
• Bawankar P, Samant P, Lahane T, et al. Mean platelet volume and central retinal vein occlusion in hypertensive patients. Can J Ophthalmol. 2019;54(2):275–279. doi:10.1016/j.jcjo.2018.04.014.
   PubMed Web of Science ®Google Scholar
• Sahin A, Sahin M, Yuksel H, et al. The mean platelet volume in patients with retinal vein occlusion. J Ophthalmol. 2013;2013:236371. doi:10.1155/2013/236371.
   PubMed Web of Science ®Google Scholar